Clinical Trial Update: A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Beclomethasone Dipropionate delivered via breath-actuated inhaler vs metered-dose inhaler in children aged 4-11 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Beclomethasone Dipropionate (beclomethasone dipropionate)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2018-02-12